VRP.L Share News (VRP)
VRP Share
VRP Share
VRP Share
VRP Share
VRP
VRP Share
VRP Broker
VRP Directors
VRP Financial
VRP
VRP Short
VRPThu, 29th Oct 2020 19:09
Verona Pharma PLC - clinical-stage biopharmaceutical company - Pretax loss in third quarter ended September 30 widens to USD22.2 million from USD15.7 million a year earlier. For nine-months to September, loss stretches to USD47.1 million from USD38.7 million.
Current stock price: 51.00 pence
Year-to-date change: down 18%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Verona Pharma posted a widened pre-tax loss for 2014 in the run up to its lead compound's commercial development. The company posted a pre-tax loss of £3.8m for 2014, up from £2.8m a year earlier, as research costs swelled from £1.7m to £2.6m over the period. Development bore a new commercial formu
Read more